External beam radiotherapy for thyroid cancer: Patients, complications, and survival

Goodsell, Kristin E.; Ermer, Jae P.; Amjad, Wajid; Swisher‐McClure, Samuel; Wachtel, Heather

doi:10.1016/j.amjsurg.2023.01.009

Cited by 6 publications

(1 citation statement)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Optimal EBRT doses (45-70 Gy) and subsequent hypofractionation (> 5 Gy) reduce local recurrence and mortality. Furthermore, radiation therapy may synergize with immunotherapy, although its efficacy remains limited alongside targeted therapy like Lenvatinib[ 14 ].…”

Section: Management Of Anaplastic Thyroid Carcinomamentioning

confidence: 99%

Anaplastic thyroid cancer: Unveiling advances in diagnosis and management

Dey,

Yadav

2024

World J Clin Oncol

View full text Add to dashboard Cite

The review article by Pavlidis et al published in World J Clin Oncol provides a meticulous analysis of the intricacies surrounding anaplastic carcinoma of the thyroid. Thyroid carcinoma encompasses a spectrum of diseases, each characterized by distinct behaviors and outcomes. Diagnostic approaches encompass a diverse array of tools. Surgery remains the pivotal treatment for anaplastic thyroid carcinoma. Radiotherapy and chemotherapy offer the best overall survival in aggressive disease. Combinations of immunotherapy with targeted therapies, such as dabrafenib-trametinib, demonstrate potential for enhanced effectiveness and improved survival outcomes. Multifaceted approach fuelled by precision medicine and interdisciplinary collaboration is imperative in charting a course toward improved outcomes in this formidable malignancy.

show abstract

Section: Management Of Anaplastic Thyroid Carcinomamentioning

confidence: 99%